EndoAnchors对不良瘤颈解剖患者肾下腹主动脉瘤腔内修复术后瘤囊回缩的影响:倾向性评分分析
该观察性回顾研究纳入倾向性评分匹配的96例ESAR与96例sEVAR患者,比较不良瘤颈解剖下瘤囊演变模式,ESAR组瘤囊回缩率更高(59.4% vs 32.3%,p<0.001),5年累积回缩率65% vs 38%(p=0.003),Ia型内漏及死亡率无显著差异。
要点
- ESAR组瘤囊回缩率59.4%,高于sEVAR组的32.3%(p<0.001)。
- 5年累积瘤囊回缩率ESAR组65%,高于sEVAR组38%(p=0.003)。
- 两组Ia型内漏及其他内漏、总死亡率和动脉瘤相关死亡率无统计学显著差异。
核心结论
- 对于不良瘤颈解剖的腹主动脉瘤患者,与sEVAR相比,ESAR在中远期至5年随访中提供了更高的瘤囊回缩率,尽管Ia型内漏率相似。
- 泡状瘤颈是两组瘤囊回缩失败的预测因素。
研究设计与样本
- 观察性回顾研究,使用2010年6月至2019年12月前瞻性收集的数据。
- ESAR组数据来自PERU注册研究主要分支(标识NCT04100499),涉及8个中心;sEVAR数据来自4个中心。
- 纳入标准:除EndoAnchor外无近端移植物辅助装置、瘤颈长度≤15 mm、至少12个月随访影像。
- 采用倾向性评分匹配(PSM)对主动脉瘤颈长度、宽度、角度和装置固定类型进行匹配,最终纳入96例ESAR和96例sEVAR患者。
- 瘤囊扩张和回缩分别定义为最大瘤囊直径增加或减少>5 mm,直径变化在±5 mm范围内视为稳定;效力分析确认>80%用于瘤囊回缩评估。
主要发现
- 平均影像随访时间ESAR组44.4±21.3个月 vs sEVAR组43.0±19.6个月(p=0.643)。
- 总体瘤囊回缩患者数ESAR组57例(59.4%) vs sEVAR组31例(32.3%)(p<0.001)。
- 5年累积瘤囊回缩率ESAR组65% vs sEVAR组38%(p=0.003),利于ESAR组。
- Ia型内漏和/或其他内漏无统计学显著差异。
- 总死亡率和动脉瘤相关死亡率无统计学差异。
关键数值与推荐
- 瘤囊回缩定义为最大瘤囊直径减少>5 mm,扩张定义为增加>5 mm,±5 mm内为稳定。
- 纳入要求瘤颈长度≤15 mm且至少12个月随访影像。
临床怎么用
- 作者结论认为,对于不良瘤颈解剖的腹主动脉瘤患者,ESAR相比sEVAR在中远期至5年提供了更高的瘤囊回缩率,尽管Ia型内漏率相似。
- 作者指出泡状瘤颈是两组瘤囊回缩失败的预测因素。
- 作者提到需考虑一些重要局限性。
局限性
- 原文结论中提到需考虑一些重要局限性,但未具体列出。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze sac evolution patterns in matched patients with hostile neck anatomy (HNA) treated with standard endovascular aneurysm repair (sEVAR) and endosutured aneurysm repair (ESAR). METHODS: Observational retrospective study using prospectively collected data between June 2010 and December 2019. ESAR group data were extracted from the primary arm of the PERU registry with an assigned identifier (NCT04100499) at 8 centers and those from the sEVAR came from 4 centers. Suitability for inclusion required: no proximal endograft adjuncts (besides EndoAnchor use), ≤15 mm neck length and minimum of 12-months follow-up imaging. Bubble-shaped neck (noncylindrical short neck with discontinuous seal) aspect was analyzed. Both groups were analyzed using propensity score matching (PSM) for aortic neck length, width, angulation, and device fixation type. Main outcome assessed was sac evolution patterns (sac expansion and regression were defined as >5mm increase or decrease, of the maximum sac diameter respectively; all AAAs within this ±5 mm range in diameter change were considered stable) and secondary outcomes were type-Ia endoleaks; other endoleaks and mortality. A power analysis calculation >80% was confirmed for sac regression evaluation. RESULTS: After exclusions, PSM resulted in 96 ESAR and 96 sEVAR patients. Mean imaging follow-up (months) was 44.4±21.3 versus 43.0±19.6 (p=0.643), respectively. The overall number of patients achieving sac regression was higher in the ESAR group (n=57, 59.4% vs n=31, 32.3%; p<0.001) and the cumulative sac regression achieved at 5 years was 65% versus 38% (p=0.003) in favor of the ESAR group. There were no statistically significant differences in type-Ia endoleak and/or other endoleaks. Univariate analysis for sac regression patients in the sEVAR and ESAR group individually showed the bubble-shape neck as a predictor of sac regression failure. There were no statistical differences in overall and aneurysm-related mortality. CONCLUSION: Endosutured aneurysm repair provided improved rates of sac regression for patients with AAA and HNA when compared with sEVAR at midterm and up to 5 years, despite similar rates of type-Ia endoleaks, and the need to consider some important limitations. The presence of bubble-shaped neck was a predictor of sac regression failure for both groups equally. CLINICAL IMPACT: The use of EndoAnchors aids and improves EVAR treatment in hostile neck anatomies by an increased rate of sac regression when compared to EVAR treatment alone in up to 5 year analysis. Moreover, a trend to reduced number of type Ia endoleaks is also achieved, although not significant in the present study. This data, adds to current and growing evidence on the usefulness of EndoAnchors for AAA endovascular treatment.
引用
- Reyes Valdivia A, Oikonomou K, Milner R, et al. The Effect of EndoAnchors on Aneurysm Sac Regression for Patients Treated With Infrarenal Endovascular Repair With Hostile Neck Anatomies: A Propensity Scored Analysis. J Endovasc Ther. 2022. PMID: 36214450. doi:10.1177/15266028221127839
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。